United Kingdom
# |
Name |
EBIT |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 8.71 B
|
Dec. 31, 2023 | USD 15.79 | -2.73% |
|
United Kingdom |
|
2 |
USD 8.49 B
|
Dec. 31, 2023 | USD 129.77 | -1.69% |
|
United Kingdom |
|
3 |
USD 3.46 B
|
Dec. 31, 2023 | USD 59.37 | -0.51% |
|
United Kingdom |
|
4 |
USD 3.30 B
|
Dec. 31, 2023 | USD 45.94 | 0.03% |
|
United Kingdom |
|
5 |
USD 2.61 B
|
Dec. 31, 2023 | USD 4.48 | -0.21% |
|
United Kingdom |
|
6 |
USD 619.00 M
|
Dec. 31, 2023 | USD 24.44 | -0.21% |
|
United Kingdom |
|
7 |
USD 468.24 M
|
March 31, 2024 | USD 32.51 | 0.69% |
|
United Kingdom |
|
8 |
USD 429.00 M
|
Dec. 31, 2023 | USD 11.94 | -0.50% |
|
United Kingdom |
|
9 |
USD 280.10 M
|
Dec. 31, 2023 | USD 2.80 | 1.24% |
|
United Kingdom |
|
10 |
USD 63.16 M
|
June 30, 2024 | USD 9.99 | -0.88% |
|
United Kingdom |
|
11 |
USD 26.22 M
|
Dec. 31, 2023 | USD 2.66 | 14.48% |
|
United Kingdom |
|
12 |
USD 25.62 M
|
Sept. 30, 2024 | USD 5.40 | -1.25% |
|
United Kingdom |
|
13 |
USD 14.38 M
|
Dec. 31, 2023 | USD 0.21 | 6.16% |
|
United Kingdom |
|
14 |
USD 13.45 M
|
June 30, 2024 | USD 39.06 | 2.49% |
|
United Kingdom |
|
15 |
USD 13.02 M
|
Dec. 31, 2023 | USD 0.78 | 0.09% |
|
United Kingdom |
|
16 |
USD 10.70 M
|
Sept. 30, 2024 | USD 18.48 | 0.49% |
|
United Kingdom |
|
17 |
USD 9.24 M
|
June 30, 2024 | USD 4.76 | -2.41% |
|
United Kingdom |
|
18 |
USD 9.11 M
|
April 30, 2024 | USD 0.64 | 0.47% |
|
United Kingdom |
|
19 |
USD 7.06 M
|
March 31, 2024 | USD 2.90 | -3.96% |
|
United Kingdom |
|
20 |
USD 5.85 M
|
Dec. 31, 2023 | USD 6.20 | -2.97% |
|
United Kingdom |
|
21 |
USD 5.76 M
|
Dec. 31, 2023 | USD 2.92 | -0.33% |
|
United Kingdom |
|
22 |
USD 5.47 M
|
Dec. 30, 2023 | USD 72.03 | -1.91% |
|
United Kingdom |
|
23 |
USD 4.65 M
|
March 31, 2024 | USD 0.78 | -0.69% |
|
United Kingdom |
|
24 |
USD 4.20 M
|
Dec. 31, 2023 | USD 0.46 | 0.09% |
|
United Kingdom |
|
25 |
USD 3.27 M
|
July 31, 2024 | USD 0.16 | -0.69% |
|
United Kingdom |
|
26 |
USD 2.81 M
|
Dec. 31, 2023 | USD 0.31 | 0.09% |
|
United Kingdom |
|
27 |
USD 1.41 M
|
June 30, 2024 | USD 1.47 | -0.73% |
|
United Kingdom |
|
28 |
USD 124.62 K
|
Sept. 30, 2023 | USD 0.04 | 0.09% |
|
United Kingdom |
|
29 |
USD -19.61 K
|
March 31, 2024 | USD 1.03 | NA |
|
United Kingdom |
|
30 |
USD -531.00 K
|
Dec. 31, 2023 | USD 0.70 | -2.31% |
|
United Kingdom |
|
31 |
USD -1.39 M
|
Dec. 31, 2023 | USD 0.13 | -2.30% |
|
United Kingdom |
|
32 |
USD -1.70 M
|
June 30, 2024 | USD 0.10 | 0.09% |
|
United Kingdom |
|
33 |
USD -2.06 M
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
34 |
USD -2.29 M
|
Dec. 31, 2023 | USD 0.02 | 2.68% |
|
United Kingdom |
|
35 |
USD -2.44 M
|
March 31, 2024 | USD 0.15 | 0.09% |
|
United Kingdom |
|
36 |
USD -2.46 M
|
Dec. 31, 2023 | USD 0.04 | -9.47% |
|
United Kingdom |
|
37 |
USD -2.60 M
|
Dec. 31, 2023 | USD 0.21 | 0.09% |
|
United Kingdom |
|
38 |
USD -2.77 M
|
Sept. 30, 2024 | USD 0.14 | 0.09% |
|
United Kingdom |
|
39 |
USD -2.88 M
|
March 31, 2024 | USD 0.11 | -6.40% |
|
United Kingdom |
|
40 |
USD -3.67 M
|
June 30, 2024 | USD 0.19 | -3.04% |
|
United Kingdom |
|
41 |
USD -3.90 M
|
Dec. 31, 2023 | USD 0.04 | -14.59% |
|
United Kingdom |
|
42 |
USD -4.18 M
|
Dec. 31, 2023 | USD 0.49 | 0.09% |
|
United Kingdom |
|
43 |
USD -5.75 M
|
June 30, 2024 | USD 0.27 | 2.36% |
|
United Kingdom |
|
44 |
USD -5.96 M
|
Dec. 31, 2023 | USD 0.06 | 1.92% |
|
United Kingdom |
|
45 |
USD -6.17 M
|
Jan. 31, 2024 | USD 0.16 | 0.87% |
|
United Kingdom |
|
46 |
USD -6.71 M
|
March 31, 2024 | USD 2.29 | -3.78% |
|
United Kingdom |
|
47 |
USD -6.86 M
|
Aug. 31, 2023 | USD 0.16 | -0.68% |
|
United Kingdom |
|
48 |
USD -8.12 M
|
Dec. 31, 2023 | USD 4.80 | 0.73% |
|
United Kingdom |
|
49 |
USD -8.71 M
|
Dec. 31, 2023 | USD 0.05 | -16.59% |
|
United Kingdom |
|
50 |
USD -8.81 M
|
Dec. 31, 2023 | USD 0.20 | 0.09% |
|
United Kingdom |
The Pharmaceuticals company in United Kingdom with the highest EBIT is GSK plc (LSE: GSK.L) at USD 8.71 B.
The Pharmaceuticals company in United Kingdom with the lowest EBIT is Roivant Sciences Ltd. (NasdaqGS: ROIV) at USD -1.02 B.
The top 10 Pharmaceuticals companies in United Kingdom by EBIT are GSK plc, AstraZeneca PLC, Reckitt Benckiser Group plc, RELX PLC, Haleon plc, Hikma Pharmaceuticals PLC, Halma plc, Smith & Nephew plc, ConvaTec Group Plc and CVS Group plc.
The bottom 10 Pharmaceuticals companies in United Kingdom by EBIT are Roivant Sciences Ltd., Clarivate Plc, Oxford Biomedica plc, Bicycle Therapeutics plc, Centessa Pharmaceuticals plc, Autolus Therapeutics plc, COMPASS Pathways plc, Barinthus Biotherapeutics plc, Silence Therapeutics plc and Immunocore Holdings plc.